ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 1,300 | +8.3% | 0.00% | -100.0% |
| Q2 2023 | $24 | +14.3% | 1,200 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $21 | +162.5% | 1,200 | +207.7% | 0.00% | +100.0% |
| Q4 2022 | $8 | -100.0% | 390 | -85.6% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | -89.7% | 2,700 | -95.2% | 0.00% | -90.9% |
| Q2 2022 | $156,000 | +372.7% | 56,518 | +1469.9% | 0.01% | +1000.0% |
| Q1 2022 | $33,000 | +371.4% | 3,600 | +227.3% | 0.00% | – |
| Q4 2021 | $7,000 | +16.7% | 1,100 | +450.0% | 0.00% | – |
| Q3 2021 | $6,000 | -71.4% | 200 | -75.0% | 0.00% | -100.0% |
| Q2 2021 | $21,000 | +50.0% | 800 | +60.0% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | +600.0% | 500 | -90.4% | 0.00% | – |
| Q2 2020 | $2,000 | -50.0% | 5,200 | +1200.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |